On Monday, the Supreme Court heard Myriad Genetics plead their case on why they want to patent human genes. According to the biotech company, it discovered the gene linked to higher risks in breast and ovarian cancer and plans to further its research.
Subscribe to RT’s Channel
Be the first to comment on "Fight to Patent Human Genes Heard by Supreme Court"